← Open Payments lookup

NATHAN MCBRIDE: Open Payments

NPI 1114915741 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,594 in 163 payments from 19 companies in 2025. Trend: 2023 $1,913 · 2024 $2,316 · 2025 $2,594

Food & beverage: $2,594
CompanyPaymentsAmount
ABBVIE INC.37$538
Takeda Pharmaceuticals U.S.A., Inc.17$289
Janssen Biotech, Inc.14$249
PFIZER INC.30$189
Celltrion USA Inc.8$171
Aimmune Therapeutics, Inc.9$169
Ardelyx, Inc.10$169
GENZYME CORPORATION9$165
Regeneron Healthcare Solutions, Inc.5$113
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$108

Products named: RINVOQ, ENTYVIO, DUPIXENT, TREMFYA, VEGZELMA, IBSRELA, SKYRIZI, XELJANZ.

Industry payments across UT — which companies pay providers there.